Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
01 1Aptra Synthesis
02 1Tagoor Laboratories
03 1Ocimum Labs
04 1Reliance Rasayan
05 1Sudarshan Pharma
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
CAS Number : 350-03-8
End Use API :
End Use API : Imatinib Mesylate, Nilotinib, Telithromycin
About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP st...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
CAS Number : 350-03-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth...
CAS Number : 350-03-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emph...
CAS Number : 350-03-8
End Use API :
End Use API : Imatinib Mesylate, Nilotinib, Telithromycin
About the Company : RELIANCE RASAYAN PVT. LTD (RRPL) was established in 1988 and in 2016 entered in pharma solutions business. Thus started our journey of developing advanced pharmaceutical intermediates, ...
CAS Number : 350-03-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Sudarshan Pharma operates in the pharmaceutical and specialty chemicals industries. Their specialty chemicals and intermediates are used in pharma, paint, food, and adhesive sectors. Th...
LOOKING FOR A SUPPLIER?